🇺🇸 FDA
Patent

US 11718658

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

granted A61KA61K38/00A61K45/06

Quick answer

US patent 11718658 (T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof) held by MiNK Therapeutics, Inc. expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MiNK Therapeutics, Inc.
Grant date
Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61K45/06, A61P, A61P35/00